BofA Securities Double Downgrades Lyell Immunopharma (LYEL) to Underperform

October 30, 2024 6:05 AM EDT Send to a Friend
(Updated - October 30, 2024 6:18 AM EDT)

BofA Securities analyst Geoff Meacham downgraded Lyell Immunopharma (NASDAQ: LYEL) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login